Role of ASK1 and PKR in Fancc hematopoiesis

ASK1 和 PKR 在 Fancc 造血中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): Our long-term goal is to identify the mechanism(s) that Fanconi anemia (FA) proteins have in protecting hematopoietic stem/progenitor cells (HS/Ps) from apoptosis in order to design targeted therapies for prevention/treatment of bone marrow failure in FA. 80% of FA patient deaths are a direct result of a progressive marrow failure. Thus, understanding mechanisms involved in the apoptotic predisposition of FA HS/Ps is of critical importance and clinically relevant. Currently, little is known regarding the function(s) that individual FA proteins have in maintaining HS/Ps survival. Using a murine model of FA type C, we previously showed that Fancc -/- stem cells have a marked reduction in repopulating ability and Fame -/- progenitors exhibit enhanced inhibitory cytokine-induced apoptosis. Preliminary data also show that Fancc /- progenitors are hypersensitive to oxidants. Our central hypothesis is that loss of IIS/Ps via altered inhibitory cytokine and oxidant apoptotic signaling has a crucial role in the development of marrow failure in FA-C patients. Previous structure-function studies in cell lines demonstrated 2 FANCC functions, separable by FANCC" mutants. One (1) function was to protect from genotoxins, and the other was to enhance survival after IFN-y/TNF-a treatment by inhibiting double-stranded RNA-dependent kinase (PKR)-mediated apoptosis. While these studies begin to clarify distinct FANCC functions in cell lines, a critical yet unanswered question is whether these 2 functions exhibit equally important roles in enhancing the survival of primary HS/Ps. Furthermore, our preliminary data suggest that FANCC may protect cells from TNF-a and oxidant induced apoptosis through an apoptosis signal-regulating kinase 1 (ASK1) dependent pathway. We hypothesize that Fancc -/- cells exhibit both altered ASK1 and PKR apoptotic signaling, which contribute to the pro-apoptotic phenotype of Fancc -/ HS/Ps after oxidant or inhibitory cytokine treatment. The goals of this application are, 1) to determine whether PKR-dependent and -independent FANCC functions enhance Fancc -/- stem cell repopulating ability and protect from inhibitory cytokine and genotoxin treatment in vivo, 2) to determine whether ASK1 participates in Fancc -/- HS/Ps hypersensitivity to apoptotic stimuli and repopulating ability, and 3) to investigate whether inhibitory cytokine hypersensitivity in primary Fancc -/- cells involves alterations in both ASK1 and PKR apoptotic signaling.
描述(由申请人提供):我们的长期目标是确定Fanconi贫血(FA)蛋白保护造血干细胞/祖细胞(HS/Ps)免于凋亡的机制,以便设计靶向治疗FA骨髓衰竭的预防/治疗。80%的FA患者死亡是进行性骨髓衰竭的直接结果。因此,了解FA HS/Ps细胞凋亡易感性的机制具有重要的临床意义。目前,关于单个FA蛋白在维持HS/Ps存活中的功能知之甚少。利用小鼠FA C型模型,我们之前发现,Fancc -/-干细胞的再生能力显著降低,Fame -/-祖细胞表现出增强的抑制性细胞因子诱导的凋亡。初步数据还表明,Fancc /-祖细胞对氧化剂过敏。我们的中心假设是,IIS/Ps通过抑制细胞因子和氧化凋亡信号的改变而丧失,在FA-C患者骨髓衰竭的发展中起着至关重要的作用。先前的细胞系结构-功能研究显示了2种FANCC功能,可通过FANCC突变体分离。一(1)功能是保护免受基因毒素的侵害,另一个功能是通过抑制双链rna依赖性激酶(PKR)介导的细胞凋亡来提高IFN-y/TNF-a治疗后的存活率。虽然这些研究开始阐明FANCC在细胞系中的不同功能,但一个关键但尚未解决的问题是,这两种功能是否在提高原发性HS/Ps的存活中发挥同样重要的作用。此外,我们的初步数据表明,FANCC可能通过凋亡信号调节激酶1 (ASK1)依赖途径保护细胞免受TNF-a和氧化剂诱导的凋亡。我们假设Fancc -/-细胞表现出ASK1和PKR凋亡信号的改变,这有助于Fancc -/ HS/Ps在氧化或抑制性细胞因子处理后的促凋亡表型。本应用的目的是:1)确定pkr依赖和不依赖的FANCC功能是否增强了FANCC -/-干细胞的再生能力,并在体内保护FANCC -/-干细胞免受抑制性细胞因子和基因毒素的处理;2)确定ASK1是否参与FANCC -/- HS/Ps对凋亡刺激的超敏反应和再生能力。3)研究原代Fancc -/-细胞的抑制性细胞因子超敏是否涉及ASK1和PKR凋亡信号的改变。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Laura S Haneline其他文献

EXPRESSION OF FOLATE RECEPTOR ISOFORMS ON PURIFIED HEMATOPOIETIC CELL POPULATIONS. † 919
  • DOI:
    10.1203/00006450-199604001-00941
  • 发表时间:
    1996-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Laura S Haneline;Asok C Antony;D Wade Clapp
  • 通讯作者:
    D Wade Clapp

Laura S Haneline的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Laura S Haneline', 18)}}的其他基金

Anti-Angiogenic Preeclamptic Milieu Impairs Infant Lung and Vascular Development
抗血管生成先兆子痫环境损害婴儿肺和血管发育
  • 批准号:
    8814313
  • 财政年份:
    2015
  • 资助金额:
    $ 30.3万
  • 项目类别:
Anti-Angiogenic Preeclamptic Milieu Impairs Infant Lung and Vascular Development
抗血管生成先兆子痫环境损害婴儿肺和血管发育
  • 批准号:
    9144430
  • 财政年份:
    2015
  • 资助金额:
    $ 30.3万
  • 项目类别:
Anti-Angiogenic Preeclamptic Milieu Impairs Infant Lung and Vascular Development
抗血管生成先兆子痫环境损害婴儿肺和血管发育
  • 批准号:
    9274355
  • 财政年份:
    2015
  • 资助金额:
    $ 30.3万
  • 项目类别:
Circulating Endothelial Progenitor Cell Subsets
循环内皮祖细胞亚群
  • 批准号:
    8261209
  • 财政年份:
    2011
  • 资助金额:
    $ 30.3万
  • 项目类别:
Endothelial Progenitor and Vascular Dysfunction in Infants of Diabetic Mothers
糖尿病母亲的婴儿的内皮祖细胞和血管功能障碍
  • 批准号:
    8307245
  • 财政年份:
    2009
  • 资助金额:
    $ 30.3万
  • 项目类别:
Endothelial Progenitor and Vascular Dysfunction in Infants of Diabetic Mothers
糖尿病母亲的婴儿的内皮祖细胞和血管功能障碍
  • 批准号:
    7730571
  • 财政年份:
    2009
  • 资助金额:
    $ 30.3万
  • 项目类别:
Endothelial Progenitor and Vascular Dysfunction in Infants of Diabetic Mothers
糖尿病母亲的婴儿的内皮祖细胞和血管功能障碍
  • 批准号:
    7901560
  • 财政年份:
    2009
  • 资助金额:
    $ 30.3万
  • 项目类别:
Endothelial Progenitor and Vascular Dysfunction in Infants of Diabetic Mothers
糖尿病母亲的婴儿的内皮祖细胞和血管功能障碍
  • 批准号:
    8081016
  • 财政年份:
    2009
  • 资助金额:
    $ 30.3万
  • 项目类别:
GDM Effect on Maternal and Neonatal Endothelial Progenitors and Vascular Function
GDM 对孕产妇和新生儿内皮祖细胞和血管功能的影响
  • 批准号:
    7295819
  • 财政年份:
    2006
  • 资助金额:
    $ 30.3万
  • 项目类别:
GDM Effect on Maternal/Neonatal Endothelial Progenitors
GDM 对母体/新生儿内皮祖细胞的影响
  • 批准号:
    7233320
  • 财政年份:
    2006
  • 资助金额:
    $ 30.3万
  • 项目类别:

相似海外基金

ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
  • 批准号:
    6238317
  • 财政年份:
    1997
  • 资助金额:
    $ 30.3万
  • 项目类别:
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
  • 批准号:
    5210031
  • 财政年份:
  • 资助金额:
    $ 30.3万
  • 项目类别:
CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
生物信号转导中的细胞粘附
  • 批准号:
    3732412
  • 财政年份:
  • 资助金额:
    $ 30.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了